Nuclear medicine utilizes radionuclides, which are unstable atoms that emit radiation spontaneously, to examine and treat diseases such as, cancer, cardiovascular, and others.
The market growth is driven by the emergence of latest and advanced products, development in clinics and centers for diagnostic imaging, advancement in radiotracers, and increase in number of patients with cancer and cardiac ailments.
This report provides a complete quantitative data and qualitative analysis on the global market for Nuclear Medicine Equipment. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Nuclear Medicine Equipment was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Nuclear Medicine Equipment is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Nuclear Medicine Equipment, including the following market information:
Global Nuclear Medicine Equipment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Nuclear Medicine Equipment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Nuclear Medicine Equipment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Nuclear Medicine Equipment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Philips, Siemens, Digirad, Mediso Medical Imaging Systems, Toshiba, Bozlu, Neusoft, Compañía Mexicana, SurgicEye, CMR Naviscan, DDD-Diagnostic, Positron, TeraRecon, GE Healthcare, CMR Naviscan, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Hybrid SPECT
Standalone SPECT
Based on the Application:
Hospitals
Imaging Centers
Academic & Research Institutes
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Nuclear Medicine Equipment Industry
1.7 COVID-19 Impact: Nuclear Medicine Equipment Market Trends
2 Global Nuclear Medicine Equipment Quarterly Market Size Analysis
2.1 Nuclear Medicine Equipment Business Impact Assessment - COVID-19
2.1.1 Global Nuclear Medicine Equipment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Nuclear Medicine Equipment Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Nuclear Medicine Equipment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Nuclear Medicine Equipment Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Nuclear Medicine Equipment Factory Price by Manufacturers
3.3 Location of Key Manufacturers Nuclear Medicine Equipment Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Nuclear Medicine Equipment Market
3.5 Key Manufacturers Nuclear Medicine Equipment Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Nuclear Medicine Equipment Segments, By Type
4.1 Introduction
1.4.1 Hybrid SPECT
1.4.2 Standalone SPECT
4.2 By Type, Global Nuclear Medicine Equipment Market Size, 2019-2021
4.2.1 By Type, Global Nuclear Medicine Equipment Market Size by Type, 2020-2021
4.2.2 By Type, Global Nuclear Medicine Equipment Price, 2020-2021
5 Impact of Covid-19 on Nuclear Medicine Equipment Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Imaging Centers
5.5.3 Academic & Research Institutes
5.2 By Application, Global Nuclear Medicine Equipment Market Size, 2019-2021
5.2.1 By Application, Global Nuclear Medicine Equipment Market Size by Application, 2019-2021
5.2.2 By Application, Global Nuclear Medicine Equipment Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Philips
7.1.1 Philips Business Overview
7.1.2 Philips Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.1.3 Philips Nuclear Medicine Equipment Product Introduction
7.1.4 Philips Response to COVID-19 and Related Developments
7.2 Siemens
7.2.1 Siemens Business Overview
7.2.2 Siemens Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.2.3 Siemens Nuclear Medicine Equipment Product Introduction
7.2.4 Siemens Response to COVID-19 and Related Developments
7.3 Digirad
7.3.1 Digirad Business Overview
7.3.2 Digirad Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.3.3 Digirad Nuclear Medicine Equipment Product Introduction
7.3.4 Digirad Response to COVID-19 and Related Developments
7.4 Mediso Medical Imaging Systems
7.4.1 Mediso Medical Imaging Systems Business Overview
7.4.2 Mediso Medical Imaging Systems Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.4.3 Mediso Medical Imaging Systems Nuclear Medicine Equipment Product Introduction
7.4.4 Mediso Medical Imaging Systems Response to COVID-19 and Related Developments
7.5 Toshiba
7.5.1 Toshiba Business Overview
7.5.2 Toshiba Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.5.3 Toshiba Nuclear Medicine Equipment Product Introduction
7.5.4 Toshiba Response to COVID-19 and Related Developments
7.6 Bozlu
7.6.1 Bozlu Business Overview
7.6.2 Bozlu Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.6.3 Bozlu Nuclear Medicine Equipment Product Introduction
7.6.4 Bozlu Response to COVID-19 and Related Developments
7.7 Neusoft
7.7.1 Neusoft Business Overview
7.7.2 Neusoft Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.7.3 Neusoft Nuclear Medicine Equipment Product Introduction
7.7.4 Neusoft Response to COVID-19 and Related Developments
7.8 Compañía Mexicana
7.8.1 Compañía Mexicana Business Overview
7.8.2 Compañía Mexicana Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.8.3 Compañía Mexicana Nuclear Medicine Equipment Product Introduction
7.8.4 Compañía Mexicana Response to COVID-19 and Related Developments
7.9 SurgicEye
7.9.1 SurgicEye Business Overview
7.9.2 SurgicEye Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.9.3 SurgicEye Nuclear Medicine Equipment Product Introduction
7.9.4 SurgicEye Response to COVID-19 and Related Developments
7.10 CMR Naviscan
7.10.1 CMR Naviscan Business Overview
7.10.2 CMR Naviscan Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.10.3 CMR Naviscan Nuclear Medicine Equipment Product Introduction
7.10.4 CMR Naviscan Response to COVID-19 and Related Developments
7.11 DDD-Diagnostic
7.11.1 DDD-Diagnostic Business Overview
7.11.2 DDD-Diagnostic Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.11.3 DDD-Diagnostic Nuclear Medicine Equipment Product Introduction
7.11.4 DDD-Diagnostic Response to COVID-19 and Related Developments
7.12 Positron
7.12.1 Positron Business Overview
7.12.2 Positron Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.12.3 Positron Nuclear Medicine Equipment Product Introduction
7.12.4 Positron Response to COVID-19 and Related Developments
7.13 TeraRecon
7.13.1 TeraRecon Business Overview
7.13.2 TeraRecon Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.13.3 TeraRecon Nuclear Medicine Equipment Product Introduction
7.13.4 TeraRecon Response to COVID-19 and Related Developments
7.14 GE Healthcare
7.14.1 GE Healthcare Business Overview
7.14.2 GE Healthcare Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.14.3 GE Healthcare Nuclear Medicine Equipment Product Introduction
7.14.4 GE Healthcare Response to COVID-19 and Related Developments
7.15 CMR Naviscan
7.15.1 CMR Naviscan Business Overview
7.15.2 CMR Naviscan Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.15.3 CMR Naviscan Nuclear Medicine Equipment Product Introduction
7.15.4 CMR Naviscan Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Nuclear Medicine Equipment Supply Chain Analysis
8.1.1 Nuclear Medicine Equipment Supply Chain Analysis
8.1.2 Covid-19 Impact on Nuclear Medicine Equipment Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Nuclear Medicine Equipment Distribution Channels
8.2.2 Covid-19 Impact on Nuclear Medicine Equipment Distribution Channels
8.2.3 Nuclear Medicine Equipment Distributors
8.3 Nuclear Medicine Equipment Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Nuclear Medicine Equipment Industry
1.7 COVID-19 Impact: Nuclear Medicine Equipment Market Trends
2 Global Nuclear Medicine Equipment Quarterly Market Size Analysis
2.1 Nuclear Medicine Equipment Business Impact Assessment - COVID-19
2.1.1 Global Nuclear Medicine Equipment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Nuclear Medicine Equipment Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Nuclear Medicine Equipment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Nuclear Medicine Equipment Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Nuclear Medicine Equipment Factory Price by Manufacturers
3.3 Location of Key Manufacturers Nuclear Medicine Equipment Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Nuclear Medicine Equipment Market
3.5 Key Manufacturers Nuclear Medicine Equipment Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Nuclear Medicine Equipment Segments, By Type
4.1 Introduction
1.4.1 Hybrid SPECT
1.4.2 Standalone SPECT
4.2 By Type, Global Nuclear Medicine Equipment Market Size, 2019-2021
4.2.1 By Type, Global Nuclear Medicine Equipment Market Size by Type, 2020-2021
4.2.2 By Type, Global Nuclear Medicine Equipment Price, 2020-2021
5 Impact of Covid-19 on Nuclear Medicine Equipment Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Imaging Centers
5.5.3 Academic & Research Institutes
5.2 By Application, Global Nuclear Medicine Equipment Market Size, 2019-2021
5.2.1 By Application, Global Nuclear Medicine Equipment Market Size by Application, 2019-2021
5.2.2 By Application, Global Nuclear Medicine Equipment Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Philips
7.1.1 Philips Business Overview
7.1.2 Philips Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.1.3 Philips Nuclear Medicine Equipment Product Introduction
7.1.4 Philips Response to COVID-19 and Related Developments
7.2 Siemens
7.2.1 Siemens Business Overview
7.2.2 Siemens Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.2.3 Siemens Nuclear Medicine Equipment Product Introduction
7.2.4 Siemens Response to COVID-19 and Related Developments
7.3 Digirad
7.3.1 Digirad Business Overview
7.3.2 Digirad Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.3.3 Digirad Nuclear Medicine Equipment Product Introduction
7.3.4 Digirad Response to COVID-19 and Related Developments
7.4 Mediso Medical Imaging Systems
7.4.1 Mediso Medical Imaging Systems Business Overview
7.4.2 Mediso Medical Imaging Systems Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.4.3 Mediso Medical Imaging Systems Nuclear Medicine Equipment Product Introduction
7.4.4 Mediso Medical Imaging Systems Response to COVID-19 and Related Developments
7.5 Toshiba
7.5.1 Toshiba Business Overview
7.5.2 Toshiba Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.5.3 Toshiba Nuclear Medicine Equipment Product Introduction
7.5.4 Toshiba Response to COVID-19 and Related Developments
7.6 Bozlu
7.6.1 Bozlu Business Overview
7.6.2 Bozlu Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.6.3 Bozlu Nuclear Medicine Equipment Product Introduction
7.6.4 Bozlu Response to COVID-19 and Related Developments
7.7 Neusoft
7.7.1 Neusoft Business Overview
7.7.2 Neusoft Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.7.3 Neusoft Nuclear Medicine Equipment Product Introduction
7.7.4 Neusoft Response to COVID-19 and Related Developments
7.8 Compañía Mexicana
7.8.1 Compañía Mexicana Business Overview
7.8.2 Compañía Mexicana Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.8.3 Compañía Mexicana Nuclear Medicine Equipment Product Introduction
7.8.4 Compañía Mexicana Response to COVID-19 and Related Developments
7.9 SurgicEye
7.9.1 SurgicEye Business Overview
7.9.2 SurgicEye Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.9.3 SurgicEye Nuclear Medicine Equipment Product Introduction
7.9.4 SurgicEye Response to COVID-19 and Related Developments
7.10 CMR Naviscan
7.10.1 CMR Naviscan Business Overview
7.10.2 CMR Naviscan Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.10.3 CMR Naviscan Nuclear Medicine Equipment Product Introduction
7.10.4 CMR Naviscan Response to COVID-19 and Related Developments
7.11 DDD-Diagnostic
7.11.1 DDD-Diagnostic Business Overview
7.11.2 DDD-Diagnostic Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.11.3 DDD-Diagnostic Nuclear Medicine Equipment Product Introduction
7.11.4 DDD-Diagnostic Response to COVID-19 and Related Developments
7.12 Positron
7.12.1 Positron Business Overview
7.12.2 Positron Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.12.3 Positron Nuclear Medicine Equipment Product Introduction
7.12.4 Positron Response to COVID-19 and Related Developments
7.13 TeraRecon
7.13.1 TeraRecon Business Overview
7.13.2 TeraRecon Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.13.3 TeraRecon Nuclear Medicine Equipment Product Introduction
7.13.4 TeraRecon Response to COVID-19 and Related Developments
7.14 GE Healthcare
7.14.1 GE Healthcare Business Overview
7.14.2 GE Healthcare Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.14.3 GE Healthcare Nuclear Medicine Equipment Product Introduction
7.14.4 GE Healthcare Response to COVID-19 and Related Developments
7.15 CMR Naviscan
7.15.1 CMR Naviscan Business Overview
7.15.2 CMR Naviscan Nuclear Medicine Equipment Quarterly Production and Revenue, 2020
7.15.3 CMR Naviscan Nuclear Medicine Equipment Product Introduction
7.15.4 CMR Naviscan Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Nuclear Medicine Equipment Supply Chain Analysis
8.1.1 Nuclear Medicine Equipment Supply Chain Analysis
8.1.2 Covid-19 Impact on Nuclear Medicine Equipment Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Nuclear Medicine Equipment Distribution Channels
8.2.2 Covid-19 Impact on Nuclear Medicine Equipment Distribution Channels
8.2.3 Nuclear Medicine Equipment Distributors
8.3 Nuclear Medicine Equipment Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
